The reason neglected diseases are called as such is due to the lack of attention given to them by drug developers, government officials, public health programs, and the media. Although the cost of producing drugs for some of these diseases can be low, the people suffering from these diseases often cannot afford to treat the diseases. Thus, private pharmaceutical companies aren’t always able to develop and produce treatments. Additionally, neglected diseases most commonly affect underdeveloped nations, and they aren’t considered high priorities for prevention and treatment. Another reason neglected diseases are overlooked is that they don’t cause dramatic outbreaks. Rather, they take effect over long periods, leading to deformities, disabilities, and relatively slow deaths.